Adenoviral vector products require RCA testing, which can be a bottleneck for lot release. Our solution? Join this webinar to learn how a new rapid RCA assay in development can help expedite release testing. Register now here, https://t.co/HBzaht6TkS
We love when math tells the story. Trust our expert partners to perform your IND and BLA-enabling studies. It’s not too late to book for early 2022! https://t.co/qoAwOIJILj #bioreliance#viralclearance
Congrats to @MilliporeSigma for being a winner in the Analytical/Test category for its Blazar™ Platform. MilliporeSigma’s innovative Blazar™ platform reduces turn-around-time from up to 63 days to ten days, while testing for 25 additional and emerging viral risks. #RD100
The COVID-19 pandemic has highlighted concerns of animal virus contamination of raw materials. Dr. Danny Galbraith shares insights to protect your process. #COVID19
Detecting the next permutations of COVID-19. Dr. Danny Galbraith discusses methods to predict virus mutations and recombination. . #COVID19#MilliporeSigma#Biopharma
We’re engaging the biopharma community to prioritize biosafety testing. Just as we did during Zika, SARS, and Ebola outbreaks, we’re here to support vaccine and therapeutic developers & mfrs. Contact us https://t.co/n1fqiFgyRG @MilliporeSigma#covid19#biopharma#vaccines#DCVMN
We’re here to support vaccine and therapeutic developers & mfrs to deliver therapies. Our facilities are operating and we’re prioritizing biosafety testing. Contact us. https://t.co/DtvLs7JxHe @MilliporeSigma#covid19#biopharma#vaccines#DCVMN
Planning your trip to Society of Toxicology? Meet us at booth #631 and don't miss these powerful poster presentations. #2020sot https://t.co/XleaVc3Nod
What if you have a positive in vitro assay? Don't panic. Our study directors are @ booth 631 at Society of Toxicology. #2020sot https://t.co/QOYto0vXbG
Join us at #ACTOX2019 as we tackle the tough questions at booth 304. Nov 20th Dr. Kulkarni presents on GeneTox Assays for Impurities Testing https://t.co/iuO8WHzeta